⌘K
Paras Healthcare IPO is a book-built issue of ₹1450.0 Cr, comprising a fresh issue of ₹500.0 Cr and an offer for sale of ₹950.0 Cr. The company operates as a healthcare provider in North India, Bihar, and Jharkhand, focusing on tertiary and quaternary care. While demonstrating strong revenue growth and improving profitability, the company faces significant risks including high debt levels and a promoter group member listed in the CIBIL defaulter database. The IPO is priced at a P/E of 37.72x post-IPO, which is reasonable compared to peers, but the Price-to-Book is very high at 15.73x. Current grey market premium indicates positive sentiment.
While the company demonstrates strong growth, improving profitability, and a favorable market sentiment (GMP), these positives are substantially offset by the governance concerns and financial leverage. The valuation is mixed, with a reasonable P/E but a very high P/B. Investors seeking listing gains might consider applying, but long-term investors should exercise caution and monitor risk mitigation closely.
The current GMP of 16.59% indicates strong investor interest and a high probability of listing gains. The company's improving financials and reasonable P/E relative to peers also support this.
While listing gains are likely, the high debt levels and significant governance risks (CIBIL defaulter) could cap short-term upside post-listing. Sustained positive performance is needed to overcome these concerns.
The company operates in a growing sector with a strong regional presence and improving profitability. However, the critical governance risks, high debt, and low return ratios pose substantial long-term challenges that require careful monitoring and resolution by management.
Listing-day performance is not available yet. It will appear here once this IPO has listed and results are recorded.
| Category | Shares Offered | % of Issue | Share |
|---|---|---|---|
| QIB | — | 75% | |
| Retail | — | 10% | |
| NII | — | 15% |
Grey-market premium history is not yet available for this issue.
Premium gain of 16.59% over issue price.
Subscription opens on 21 Oct. Live demand will appear here.
Strong revenue growth (approx. 20% CAGR FY24-FY26).
Significant improvement in profitability, moving from losses to positive PAT and expanding margins.
One of the largest healthcare providers in North India, Bihar, and Jharkhand with a first-mover advantage.
Well-recognized brand and strong focus on tertiary and quaternary care.
Clear growth strategies including scaling operations and network expansion.
Positive operating cash flow generation.
Attractive post-IPO P/E valuation compared to industry peers.
Strong pre-issue promoter holding (72.8%).
Healthy Grey Market Premium (GMP) indicating strong investor interest.
Successful execution of expansion plans, continued improvement in operational efficiency and payor mix, strong demand for tertiary/quaternary care, and favorable regulatory environment.
Steady growth in existing operations, moderate success in new hospital scaling, stable industry growth, and effective debt management.
Failure to address promoter governance issues, inability to manage high debt, intense competition, adverse regulatory changes, and slower-than-expected market growth.
Positive: Strong revenue growth (approx. 20% CAGR FY24-FY26).
Red flag: high leverage (D/E 3.21) -> -12.0 pts on fundamentals
Listing-gain vs long-term: Neutral / Avoid.
Concern: Promoter group member listed in CIBIL wilful defaulter database (critical governance risk).